Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Friday, May 16, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
admin
-
April 11, 2025
Latest Pharma-News
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
admin
-
April 9, 2025
Latest Pharma-News
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
admin
-
April 9, 2025
Latest Pharma-News
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
admin
-
April 9, 2025
Latest Pharma-News
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
admin
-
February 10, 2025
Latest Pharma-News
New vaccine platform used to develop COVID-19 candidates
admin
-
April 8, 2020
0
Latest Pharma-News
Izana intiates study assessing namilumab for COVID-19
admin
-
April 8, 2020
0
Latest Pharma-News
Novartis announces plan to initiate clinical study of Jakavi® in severe COVID-19 patients and establish international compassionate use program
admin
-
April 8, 2020
0
Latest Pharma-News
FDA Accepts IND for NK Cell Therapy CYNK-001 to Treat Patients with COVID-19
admin
-
April 7, 2020
0
Latest Pharma-News
Coronavirus (COVID-19) Update: FDA Continues to Accelerate Development of Novel Therapies for COVID-19
admin
-
April 5, 2020
0
Latest Pharma-News
Sanofi: First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19
admin
-
April 5, 2020
0
Latest Pharma-News
Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19
admin
-
April 5, 2020
0
Latest Pharma-News
Coronavirus (COVID-19) Update: FDA Coordinates National Effort to Develop Blood-Related Therapies for COVID-19
admin
-
April 5, 2020
0
Latest Pharma-News
Imfinzi approved in the US for extensive-stage small cell lung cancer
admin
-
March 30, 2020
0
Latest Pharma-News
Farxiga reduced the incidence of heart failure worsening or cardiovascular death in a sub-analysis from landmark Phase III DAPA-HF trial
admin
-
March 30, 2020
0
Latest Pharma-News
Farxiga Phase III DAPA-CKD trial will be stopped early after overwhelming efficacy in patients with chronic kidney disease
admin
-
March 30, 2020
0
Latest Pharma-News
EMA Accepts Arvelle Therapeutics’ MAA for Cenobamate for the Adjunctive Treatment of Focal-Onset Seizures in Adults
admin
-
March 29, 2020
0
1
...
125
126
127
...
145
Page 126 of 145
- Advertisment -
Most Read
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
April 11, 2025
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
April 9, 2025
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
April 9, 2025
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
April 9, 2025